ロード中...

hGBP-1 Expression Predicts Shorter Progression-Free Survival in Ovarian Cancers, While Contributing to Paclitaxel Resistance

Ovarian cancer is the gynecological cancer with the poorest prognosis. One significant reason is the development of resistance to the chemotherapeutic drugs used in its treatment. The large GTPase, hGBP-1, has been implicated in paclitaxel resistance in ovarian cell lines. Forced expression of hGBP-...

詳細記述

保存先:
書誌詳細
出版年:J Cancer Ther
主要な著者: Wadi, Suzan, Tipton, Aaron R., Trendel, Jill A., Khuder, Sadik A., Vestal, Deborah J.
フォーマット: Artigo
言語:Inglês
出版事項: 2016
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5226657/
https://ncbi.nlm.nih.gov/pubmed/28090373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4236/jct.2016.713097
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!